Crystal Nucleation Using Surface-Energy-Modified Glass Substrates

被引:5
作者
Nordquist, Kyle A. [1 ]
Schaab, Kevin M. [1 ]
Sha, Jierui [1 ]
Bond, Andrew H. [1 ]
机构
[1] DeNovX, Lab 204 S, 3440 South Dearborn St, Chicago, IL 60616 USA
基金
美国国家卫生研究院;
关键词
SELF-ASSEMBLED MONOLAYERS; HETEROGENEOUS NUCLEATION; PROTEIN CRYSTALLIZATION; CHEMISTRY; REMOVAL; GROWTH; GOLD;
D O I
10.1021/acs.cgd.7b00574
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Systematic surface energy modifications to glass substrates can induce nucleation and improve crystallization outcomes for small molecule active pharthaceutical ingredients (APIs) and proteins. A comparatively broad probe for function is presented in which various APIs, proteins, organic solvents, aqueous media, surface energy motifs, crystallization methods, form factors, and flat and convex surface energy modifications were examined. Replicate studies (n >= 6) have demonstrated an average :reduction in crystallization onset times of 52(4)% (alternatively 52 +/- 4%) for acetylsalicylic acid from 91% isopropyl alcohol using two very different techniques: bulk cooling to 0 degrees C using flat surface energy modifications or microdomain cooling to 4 degrees C from the interior of a glass capillary having convex surface energy modifications that were immersed in the solution. For thauinatin and bovine pancreatic trypsin, a 32(2)% reduction in crystallization onset times was demonstrated in vapor diffusion experiments (n >= 15). Nucleation site arrays have been engineered onto form factors frequently used in crystallization screening, including microscope slides, vials, and 96- and 384-well high-throughput screening plates. Nucleation using surface energy modifications on the, vessels that contain the solutes to be crystallized adds a layer of useful variables to crystallization studies without requiring significant changes to workflows or instrumentation.
引用
收藏
页码:4049 / 4055
页数:7
相关论文
共 34 条
  • [1] Solid form screening - A review
    Aaltonen, Jaakko
    Alleso, Morten
    Mirza, Sabiruddin
    Koradia, Vishal
    Gordon, Keith C.
    Rantanen, Jukka
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (01) : 23 - 37
  • [2] Aldridge S, 2007, CHEM WORLD-UK, V4, P64
  • [3] Polymorph Screening: Comparing a Semi-Automated Approach with a High Throughput Method
    Alvarez, Alejandro J.
    Singh, Aniruddh
    Myerson, Allan S.
    [J]. CRYSTAL GROWTH & DESIGN, 2009, 9 (09) : 4181 - 4188
  • [4] [Anonymous], 2010, QIAG US M PRES PROT
  • [5] Babnigg G., 2014, COMMUNICATION
  • [6] Babnigg Gyoergy, 2010, Journal of Structural and Functional Genomics, V11, P71, DOI 10.1007/s10969-010-9080-0
  • [7] Pearl drops
    Bico, J
    Marzolin, C
    Quéré, D
    [J]. EUROPHYSICS LETTERS, 1999, 47 (02): : 220 - 226
  • [8] Bond A. H., 2015, S. Patent, Patent No. [9,193,664, 9193664]
  • [9] Pharmaceutical Crystallization
    Chen, Jie
    Sarma, Bipul
    Evans, James M. B.
    Myerson, Allan S.
    [J]. CRYSTAL GROWTH & DESIGN, 2011, 11 (04) : 887 - 895
  • [10] From Tailored Supports to Controlled Nucleation: Exploring Material Chemistry, Surface Nanostructure, and Wetting Regime Effects in Heterogeneous Nucleation of Organic Molecules
    Di Profio, Gianluca
    Fontananova, Enrica
    Curcio, Efrem
    Drioli, Enrico
    [J]. CRYSTAL GROWTH & DESIGN, 2012, 12 (07) : 3749 - 3757